OTLK
Outlook Therapeutics Inc

16,939
Loading...
Loading...
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23

Frequently Asked Questions

What is Market Cap of Outlook Therapeutics Inc?
What is the 52-week high for Outlook Therapeutics Inc?
What is the 52-week low for Outlook Therapeutics Inc?
What is Outlook Therapeutics Inc stock price today?
What was Outlook Therapeutics Inc stock price yesterday?
What is the PE ratio of Outlook Therapeutics Inc?
What is the Price-to-Book ratio of Outlook Therapeutics Inc?
What is the 50-day moving average of Outlook Therapeutics Inc?
How many employess does Outlook Therapeutics Inc has?

Latest OTLK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.